摘要
目的探讨生脉注射液联合果糖二磷酸钠治疗病毒性心肌炎的疗效。方法将52例病毒性心肌炎患者随机分为两组,对照组予以常规治疗加生脉注射液,治疗组在常规治疗基础上加生脉注射液和果糖二磷酸钠。结果两组患者病情均得到明显改善,对照组临床治愈14例,显效2例,有效1例,无效3例;治疗组临床治愈26例,显效2例,有效3例,无效1例,两组疗效比较差异有统计学意义(P<0.05)。结论生脉注射液联用果糖二磷酸钠对病毒性心肌炎急性期发病过程中的治疗及预后均有良好作用。
Objective This study is to evaluate the efficacy of the combination therapy of shengmai injection and fructose diphosphate sodium on viral myocarditis. Methods 52 of clinically diagnosed patients of viral myoearditis were selected for this study. They were randomly divided into two groups ： control group with regular treatment plus shengmai injection, treatment group with regular treatment plus shengmai injection and fructose diphosphate sodium. Results The patients＇ conditions of the two groups were significantly improved, the efficiency rates of the control group and treatment group were 85.00% and 96. 88%, respectively. The treatment group showed a significantly difference compared with control group （ P 〈 0. 05 ）. Conclusion The observed effect of the combination therapy shengmai injection and fructose diphosphate suggests that it can be effectively used for the treatment and prognosis of viral myoearditis.
出处
《实用心脑肺血管病杂志》
2009年第11期960-961,共2页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词
生脉注射液
果糖二磷酸钠
病毒性心肌炎
Shengmai injection
Fructose diphosphate sodium
Viral myocarditis
